|
End-of-day quote
NSE India S.E.
19/10/2026
|
5-day change | 1st Jan Change | ||
| 1,766.60 INR | -2.97% |
|
-5.40% | +29.47% |
| Market Cap | 335B 3.54B 3.15B 2.92B 2.64B 4.97B 5.05B 35.01B 13.75B 175B 13.27B 12.99B 559B | P/E 2027 * |
28.2x | P/E 2028 * | 23x |
|---|---|---|---|---|---|
| Enterprise Value | 341B 3.6B 3.21B 2.97B 2.69B 5.06B 5.15B 35.68B 14.02B 179B 13.52B 13.24B 570B | EV / Sales 2027 * |
3.22x | EV / Sales 2028 * | 2.78x |
| Free-Float |
22.18% | Yield 2027 * |
0.23% | Yield 2028 * | 0.27% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| EMCURE | End-of-day quote | |
Bombay S.E.
| EMCURE | Delayed |
Last Transcript: Emcure Pharmaceuticals Limited
| 1 day | -2.97% | ||
| 1 week | -5.40% | ||
| Current month | -9.08% | ||
| 1 month | -11.84% | ||
| 3 months | -0.93% | ||
| 6 months | +5.65% | ||
| Current year | +29.47% |
| 1 week | 1,746.5 |  | 1,887.9 |
| 1 month | 1,746.5 | | 2,045 |
| Current year | 1,381 | | 2,100.7 |
| 1 year | 1,306.5 | | 2,100.7 |
| 3 years | 889 | | 2,100.7 |
| 5 years | 889 | | 2,100.7 |
| 10 years | 889 | | 2,100.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 15/04/1981 | |
| Director of Finance/CFO | - | 30/09/2003 | |
| Compliance Officer | - | 03/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 73 | 22/07/2001 | |
| Chairman | 75 | 20/09/2026 | |
| Director/Board Member | 49 | 27/07/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.97% | -5.40% | +31.10% | - | 3.53B | |
| +4.23% | +11.19% | +60.33% | +121.85% | 1,106B | |
| +2.31% | +4.27% | +33.81% | +69.43% | 612B | |
| +2.76% | +5.88% | +25.17% | +98.65% | 500B | |
| +2.58% | +8.37% | +38.71% | +63.14% | 367B | |
| +3.31% | +4.36% | +71.65% | +44.31% | 354B | |
| +1.85% | +6.04% | +21.47% | +49.17% | 286B | |
| +1.76% | +6.07% | +0.43% | +20.98% | 256B | |
| +2.44% | +5.63% | +43.76% | +56.40% | 230B | |
| +1.89% | +5.39% | +26.63% | +100.39% | 190B | |
| Average | +1.94% | +1.37% | +35.31% | +69.37% | 390.37B | |
| Weighted average by Cap. | +2.86% | +2.29% | +41.25% | +81.23% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 106B 1.12B 996M 923M 837M 1.57B 1.6B 11.08B 4.35B 55.5B 4.2B 4.11B 177B | 119B 1.26B 1.12B 1.04B 943M 1.77B 1.8B 12.49B 4.9B 62.53B 4.73B 4.63B 199B |
| Net income | 11.89B 126M 112M 104M 93.86M 176M 179M 1.24B 488M 6.22B 471M 461M 19.86B | 14.54B 154M 137M 127M 115M 216M 219M 1.52B 597M 7.61B 576M 564M 24.28B |
| Net Debt | 6.38B 67.39M 59.98M 55.59M 50.38M 94.68M 96.26M 667M 262M 3.34B 253M 248M 10.66B | -3.28B -34.6M -30.8M -28.55M -25.87M -48.61M -49.43M -343M -135M -1.72B -130M -127M -5.47B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/10/26 | ₹1,766.60 | -2.97% | 108,214 |
| 16/10/26 | ₹1,820.60 | -0.84% | 39,565 |
| 15/10/26 | ₹1,836.00 | -1.62% | 66,977 |
| 14/10/26 | ₹1,866.20 | -0.13% | 157,573 |
| 13/10/26 | ₹1,868.60 | +0.06% | 55,653 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions
